Eli Lilly's popular drug Mounjaro stuck at Indian regulators' counter 0 04.07.2024 09:39 Business Standard Eli Lilly's Mounjaro, a blockbuster diabetes medication and a highly popular obesity treatment is still awaiting approval from CDSCO despite a SEC clearance Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
